BOCA RATON, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- If you are a little hazy on the new hemp legislation, you’re not the only one. While the dietary supplement industry is rejoicing over the passing of the 2018 U.S. farm bill, consumers who are looking for CBD products on retailers’ shelves in the new year will likely be met with more confusion when it comes to the safety, efficacy and legality of CBD (cannabidiol). To provide guidance on CBD uses and purchases, Twinlab Consolidated Holdings, Inc. (OTCPK:TLCC) ("TCC" or "Twinlab") will host a bi-monthly video podcast, “The Science of CBD,” to clear up the confusion on the benefits and effectiveness of this sought-after supplement.

With more than 50 years of experience in the dietary supplement and nutraceuticals industry, Twinlab has been a trusted name for consumers when it comes to nutrition needs and has earned a reputation in the industry for transparency, accuracy and education. The research and development team at Twinlab has been analyzing the research on CBD and other phytocannabinoids for more than a decade and recognizes the immense untapped potential in its use with a variety of health issues of significant interest to millions of Americans.

“We want to equip consumers with science-based facts on phytocannabinoids and hemp so they know how to use CBD effectively,” said Anthony Zolezzi, CEO of Twinlab. “We believe natural products will revolutionize health care and CBD products will be responsible for the biggest expansion the natural products industry has experienced in recent years, and want to ensure that consumers are informed to make smart decisions when it comes to dosing, frequency, cost and usage.”

Gene Bruno, MS, MHS, professor of Nutraceutical Sciences at Huntington University, and director of formulation at Twinlab will host “The Science of CBD” video podcast. In each episode, he will cover topics critical to the understanding and proper use of hemp, CBD and phytocannabinoids, while dispelling myths related to CBD and its uses. Topics covered will include: the legality of hemp, research-based dosages, mechanisms and indications, while comparing specific types of phytocannabinoids and products. Bruno will simplify and breakdown scientific literature related to CBD research to explain the latest developments for using phytocannabinoids, which include CBD for health maintenance and lifestyle-enhancing applications. Guest experts will join the show and lend additional insight on CBD use, from selecting the right formula to understanding other beneficial hemp compounds that enhance the effect of phytocannabinoids for sleep, pain and stress related anxiety.

“Twinlab is a leader in phytocannabinoid supplementation because they have been refining the cultivation and extraction process for years,” said Bruno. “We want to share this information with consumers so they know how to effectively combine the balancing properties of phytocannabinoids with a complementary blend of natural calming and anti-inflammatory compounds to help improve sleep, performance and general health and wellbeing.”

Current research shows CBD can influence the brain’s anti-anxiety chemicals including GABA and serotonin to reduce occasional stress, improve REM and deep sleep, modulate pain receptor response and decrease inflammation caused by overexertion to maintain an active and healthy lifestyle. “The Science of CBD” video podcast is available in Spanish and English. To view or subscribe go to: www.twinlabcbd.com.  Consumers can also call 800-444-4860 for CBD related questions.

About Twinlab Consolidated Holdings, Inc. 
Twinlab Consolidated Holdings, Inc. ("TLCC") is the parent holding company of Twinlab Consolidation Corp., an industry-focused health and wellness company committed to developing top brands. TLCC has a portfolio of products that are made in America using the finest ingredients from around the world. In addition to its namesake brand, Twinlab®, established in 1968, TLCC, through TCC and its subsidiaries, also manufactures and sells other well-known category leaders including the Metabolife® line of diet and energy products; the Twinlab® Fuel line and newly launched REAAL® sports nutrition products; Alvita® teas, established in 1922 as a single-herb tea line; and premium nutritional and anti-aging/wellness supplements under the award winning Reserveage™ Nutrition family of brands. TCC also owns NutraScience Labs, an award-winning contract manufacturer. Visit www.tchhome.com for more information.

Forward Looking Statements
Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "seeks," "should," "will," and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control including, without limitation, those risks set forth in the "Item 1A. Risk Factors" section of the Annual Report for the year ended December 31, 2018 on Form 10-K filed by TLCC with the Securities and Exchange Commission on April 3, 2018 as updated by TLCC's other SEC filings. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7c27fe88-d30b-4b14-a57b-bcf1e7690288